Interestingly, in a recent study, non-small-cell lung cancer (NSCLC) patients homologous for the ERCC1 118 (excision repair cross-complementing 1) exhibited a significantly better survival [37]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.